scispace - formally typeset
M

Matthias Blüher

Researcher at Leipzig University

Publications -  726
Citations -  45131

Matthias Blüher is an academic researcher from Leipzig University. The author has contributed to research in topics: Adipose tissue & Insulin resistance. The author has an hindex of 90, co-authored 614 publications receiving 36644 citations.

Papers
More filters

Genetic studies of body mass index yield new insights for obesity biology

Adam E. Locke, +481 more
TL;DR: This paper conducted a genome-wide association study and meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in up to 339,224 individuals.
Journal ArticleDOI

Obesity: global epidemiology and pathogenesis.

TL;DR: Although obesity prevalence increased in every single country in the world, regional differences exist in both obesity prevalence and trends; understanding the drivers of these regional differences might help to provide guidance on which are the most promising intervention strategies.
Journal ArticleDOI

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet.

TL;DR: In this article, the authors randomly assigned 322 moderately obese subjects (mean age, 52 years; mean body-mass index [the weight in kilograms divided by the square of the height in meters], 31; male sex, 86%) to one of three diets: low-fat, restricted-calorie; Mediterranean, restricted calorie; or low-carbohydrate, non-restricted calorie.
Journal ArticleDOI

Antioxidants prevent health-promoting effects of physical exercise in humans.

TL;DR: Consistent with the concept of mitohormesis, exercise-induced oxidative stress ameliorates insulin resistance and causes an adaptive response promoting endogenous antioxidant defense capacity and supplementation with antioxidants may preclude these health-promoting effects of exercise in humans.
Journal ArticleDOI

Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

TL;DR: RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of frank diabetes and appears to identify insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations, providing a rationale for antidiabetic therapies aimed at lowering serum RBP4 levels.